go to The Japanese Society of Gastroenterological Surgery official site The Japanese Journal of Gastroenterological Surgery Online Journal
go to main navigation
go to Home
go to Current Issue
go to Past Issue
go to Article Search
Abstract go to Japanese page English
Vol.24 No.11 1991 November [Table of Contents] [Full text ( PDF 569KB)]
CASE REPORT

A Case of Malignant Hemangiopericytoma of the Retroperitoneum Successfully Treated by Combined Modality Therapy

Yoichiro Yamanaka, Masahiko Onda, Kaku Egami, Norio Matsukura, Shigeki Okazaki, Mitsuru Nakao, Takayuku Aimoto, Hitochi Watanabe, Eiji Uchida, Tadashi Kobayashi, Hiroshi Yoshida, Yasuhiro Mamada, Koji Sasajima, Kiyohiko Yamashita, Yasumasa Shirai*, Goro Asano**

First Department of Surgery, *Department of Orthopaedic Surgery, and **Department of Pathology, Nippon Medical School

A l7-year-old Japanese youth was admitted to our hospital with complaints of abdominal distension and both pain and numbness in the right lower extremity. Computed tomography and magnetic resonance imaging on admission revealed a huge tumor in the right retroperitoneum. A biopsy specimen was taken by laparotomy and it revealed malignant hemangiopericytoma. After radiation by Linac (total 40 Gy) and chemotherapy with cisplatin (total 320 mg), the tumor was reduced by 48%, to a size that would make surgical extirpation possible. After ascertaining that the tumor had not increased in size during the next 5 months, we went ahead with our original plans to perform extirpation. As a preliminary procedure to minimize bleeding during the operation, we selectively embolized of 3 right lumbar arteries and a branch of the right internal iliac artery, which were feeder vessels of the tumor. Three days later, surgical extirpation was carried out. After receiving postoperative chemotherapy, the patient was discharged from the hospital, and was followed in the Outpatient Clinic. There were no signs of recurrence or metastasis during the 13 months after the first chemotherapy, which means the patient survived for at least 1 year and 9 months after admission. Malignant hemangiopericytoma of the retroperitoneum is still rare in Japan, and the prognosis is very poor. To our knowledge, no patients have survived 2 years or longer. What makes this case noteworthy is that combined modality therapy appears to be an effective treatment for malignant hemangiopericytoma.

Key words
malignant hemangiopericytoma of retroperitoneum, combined multimodal therapy, delayed primary operation

Jpn J Gastroenterol Surg 24: 2819-2823, 1991

Reprint requests
Kaku Egami First Department of Surgery, Nippon Medical School
1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113 JAPAN

Accepted
June 5, 1991

go to download site To read the PDF file you will need Abobe Reader installed on your computer.
return to the head of this page
back to main navigation
Copyright © The Japanese Society of Gastroenterological Surgery